This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Clements, W. M. Articles by Lowy, A. M. Search for Related Content PubMed PubMed Citation Articles by Clements, W. M. Articles by Lowy, A. M.

ß-Catenin Mutation Is a Frequent Cause of Wnt Pathway Activation in Gastric Cancer¹

University of Cincinnati Department of Surgery, Division of Surgical Oncology, Cincinnati, Ohio 45219 [W. M. C., A. S., A. M. L.]; Howard Hughes Medical Institute and the University of Cincinnati Department of Molecular Genetics, Biochemistry, and Microbiology, Cincinnati, Ohio 45267 [W. M. C., A. S., J. M., J. G.]; University of Cincinnati Department of Pathology and Laboratory Medicine, Cincinnati, Ohio 45267 [J. W., O. J. K., C. F-P.]; and Department of Hematology and Oncology, St. Vincent’s Comprehensive Cancer Center, New York, New York [W. M. C., A. S., J. M., J. G.]

Studies of Wnt activation in gastric cancer have yielded conflicting results. The goals of this study were to determine the frequency of Wnt pathway activation and ß-catenin mutation in these tumors. Three hundred eleven gastric cancers were examined for ß-catenin expression by immunostaining and dissected using laser capture microscopy to obtain DNA from those tumors with nuclear ß-catenin. Exon 3 of ß-catenin was amplified using PCR and sequenced. Ninety gastric cancers (29%) displayed nuclear ß-catenin. DNAs from 73 tumors were amplified and sequenced; 19 (26%) contained mutations in exon 3 of ß-catenin, whereas no mutations were detected in 19 tumors negative for ß-catenin nuclear staining (P < 0.05). Most mutations were adjacent to or abolished known regulatory phosphorylation sites. Mutations in exon 3 of ß-catenin are common in gastric cancer that display nuclear ß-catenin. These results suggest that Wnt pathway activation contributes to carcinogenesis in a subset of gastric adenocarcinomas.

This article has been cited by other articles:

				M. Nakayama, J. Hisatsune, E. Yamasaki, H. Isomoto, H. Kurazono, M. Hatakeyama, T. Azuma, Y. Yamaoka, K. Yahiro, J. Moss, et al. Helicobacter pylori VacA-induced Inhibition of GSK3 through the PI3K/Akt Signaling Pathway J. Biol. Chem., January 16, 2009; 284(3): 1612 - 1619. [Abstract] [Full Text] [PDF]

				R. K. Wali, D. P. Kunte, J. L. Koetsier, M. Bissonnette, and H. K. Roy Polyethylene glycol-mediated colorectal cancer chemoprevention: roles of epidermal growth factor receptor and Snail Mol. Cancer Ther., September 1, 2008; 7(9): 3103 - 3111. [Abstract] [Full Text] [PDF]

				X. Guo, H. Oshima, T. Kitmura, M. M. Taketo, and M. Oshima Stromal Fibroblasts Activated by Tumor Cells Promote Angiogenesis in Mouse Gastric Cancer J. Biol. Chem., July 11, 2008; 283(28): 19864 - 19871. [Abstract] [Full Text] [PDF]

				P. S. H. Soon, K. L. McDonald, B. G. Robinson, and S. B. Sidhu Molecular Markers and the Pathogenesis of Adrenocortical Cancer Oncologist, May 1, 2008; 13(5): 548 - 561. [Abstract] [Full Text] [PDF]

				H.-T. Xu, Q. Wei, Y. Liu, L.-H. Yang, S.-D. Dai, Y. Han, J.-H. Yu, N. Liu, and E.-H. Wang Overexpression of Axin Downregulates TCF-4 and Inhibits the Development of Lung Cancer Ann. Surg. Oncol., November 1, 2007; 14(11): 3251 - 3259. [Abstract] [Full Text] [PDF]

				A Gylling, W M Abdel-Rahman, M Juhola, K Nuorva, E Hautala, H J Jarvinen, J-P Mecklin, M Aarnio, and P Peltomaki Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study Gut, July 1, 2007; 56(7): 926 - 933. [Abstract] [Full Text] [PDF]

				H. Tomita, Y. Yamada, T. Oyama, K. Hata, Y. Hirose, A. Hara, T. Kunisada, Y. Sugiyama, Y. Adachi, H. Linhart, et al. Development of Gastric Tumors in ApcMin/+ Mice by the Activation of the {beta}-Catenin/Tcf Signaling Pathway Cancer Res., May 1, 2007; 67(9): 4079 - 4087. [Abstract] [Full Text] [PDF]

				A. M. Lowy, W. M. Clements, J. Bishop, L. Kong, T. Bonney, K. Sisco, B. Aronow, C. Fenoglio-Preiser, and J. Groden {beta}-Catenin/Wnt Signaling Regulates Expression of the Membrane Type 3 Matrix Metalloproteinase in Gastric Cancer. Cancer Res., May 1, 2006; 66(9): 4734 - 4741. [Abstract] [Full Text] [PDF]

				M. L. Mucenski, J. M. Nation, A. R. Thitoff, V. Besnard, Y. Xu, S. E. Wert, N. Harada, M. M. Taketo, M. T. Stahlman, and J. A. Whitsett {beta}-Catenin regulates differentiation of respiratory epithelial cells in vivo Am J Physiol Lung Cell Mol Physiol, December 1, 2005; 289(6): L971 - L979. [Abstract] [Full Text] [PDF]

				F. Tissier, C. Cavard, L. Groussin, K. Perlemoine, G. Fumey, A.-M. Hagnere, F. Rene-Corail, E. Jullian, C. Gicquel, X. Bertagna, et al. Mutations of {beta}-Catenin in Adrenocortical Tumors: Activation of the Wnt Signaling Pathway Is a Frequent Event in both Benign and Malignant Adrenocortical Tumors Cancer Res., September 1, 2005; 65(17): 7622 - 7627. [Abstract] [Full Text] [PDF]

				S. Megy, G. Bertho, J. Gharbi-Benarous, N. Evrard-Todeschi, G. Coadou, E. Segeral, C. Iehle, E. Quemeneur, R. Benarous, and J.-P. Girault STD and TRNOESY NMR Studies on the Conformation of the Oncogenic Protein {beta}-Catenin Containing the Phosphorylated Motif DpSGXXpS Bound to the {beta}-TrCP Protein J. Biol. Chem., August 12, 2005; 280(32): 29107 - 29116. [Abstract] [Full Text] [PDF]

				H. Yamamoto, S. Horiuchi, Y. Adachi, H. Taniguchi, K. Nosho, Y. Min, and K. Imai Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over-expression of matrilysin in human gastric cancer Carcinogenesis, March 1, 2004; 25(3): 325 - 332. [Abstract] [Full Text] [PDF]

				D. M. Dorfman, H. A. Greisman, and A. Shahsafaei Loss of Expression of the WNT/{beta}-Catenin-Signaling Pathway Transcription Factors Lymphoid Enhancer Factor-1 (LEF-1) and T Cell Factor-1 (TCF-1) in a Subset of Peripheral T Cell Lymphomas Am. J. Pathol., May 1, 2003; 162(5): 1539 - 1544. [Abstract] [Full Text] [PDF]

				S. Nabais, J. C. Machado, C. Lopes, R. Seruca, F. Carneiro, and M. Sobrinho-Simoes Patterns of {beta}-Catenin Expression in Gastric Carcinoma: Clinicopathological Relevance and Mutation Analysis International Journal of Surgical Pathology, January 1, 2003; 11(1): 1 - 9. [Abstract] [PDF]